Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Search Results

Title:
Understanding Mechanisms of Response and Resistance to Androgen-Directed Therapies in Men with Advanced Prostate Cancer Through Interrogation of Tumor Biopsies
Protocol Number:
J1262
Phase:
NULL
Physician:
Emmanuel Antonarakis
Purpose:
To test the possibility of obtaining tumor biopsy samples from men with advanced prostate cancer before, during, and after treatment with a variety of androgen-directed therapies,To understand some of the mechanisms of response and resistance to androgen-directed therapies of tumors
Eligibility:
Must have recurrent or advance prostate cancer, musst be about to begin treatment with an androgen-directed therapy, be at least 18 years of age, have at least one metastatic lesion that is readily able to be biopsed, willingness to have 3 blood collections and/or up to 3 image-guided tumor biopsies or metastatic tissue
Treatment:
Samples (blood and/or tumor) will be collected before starting androgen-directed therapy, at the time of a response to treatment and at the time of treatment resistence.
Population:
Adult
Last Update
08/30/2014 04:02 AM
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

Cancer Dictionary

NCI Dictionary of Cancer Terms, a resource with more than 6,000 terms related to cancer and medicine.

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer